Julia Wind-Falk studies the impact of the pandemic on the 1972 UN Biological Weapons Convention. She analyses how rapid developments and investments in biotechnology are changing the international security landscape regarding dual-use goods and facilities. Her focus lies on integrating pandemic-related insights into existing agreements to support both the biopharmaceutical industry and research, as well as the security policy environment, thereby minimizing risks and strengthening security and ethical standards. Julia contributes through her long-term expertise from the biopharmaceutical industry, law firms, and regulatory authorities.
